Terkko Navigator / Alimentary Pharmacology & Therapeutics

Senescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection

Prospective evaluation of the impact of covert hepatic encephalopathy on quality of life and sleep in cirrhotic patients

High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication

Risk of diabetes in HIV‐infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort

Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease

Subcutaneous rather than intravenous ustekinumab induction is associated with comparable circulating drug levels and early clinical response: a pilot study

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease

Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis

The impact of ileal pouch‐anal anastomosis on graft survival following liver transplantation for primary sclerosing cholangitis

Risk of post‐operative surgical site infections after vedolizumab vs anti‐tumour necrosis factor therapy: a propensity score matching analysis in inflammatory bowel disease

Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease—authors’ reply

Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease

Editorial: post‐operative complications in elderly onset inflammatory bowel disease—what is surgery, what is disease, and what is delay of surgery? Authors’ reply

Editorial: proton pump inhibitors (PPIs) and primary liver cancer

Editorial: ustekinumab and Crohn's disease—what can we learn from long‐term extension studies?

Editorial: role of leucine‐metformin‐sildenafil combination in the treatment of nonalcoholic fatty liver disease (NAFLD)

Editorial: is sofosbuvir‐based therapy suitable for patients with advanced chronic kidney disease?

Editorial: post‐operative complications in elderly onset inflammatory bowel disease—what is surgery, what is disease, and what is delay of surgery?

Issue Information

Review article: pathogenesis of Crohn's perianal fistula—understanding factors impacting on success and failure of treatment strategies

Systematic review with meta‐analysis: online psychological interventions for mental and physical health outcomes in gastrointestinal disorders including irritable bowel syndrome and inflammatory bowel disease

Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B

Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors

Hepatic steatosis is highly prevalent across the paediatric age spectrum, including in pre‐school age children

Association between proton pump inhibitors and the risk of hepatocellular carcinoma

Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Interferon‐free therapy in hepatitis C virus mixed cryoglobulinaemia: a prospective, controlled, clinical and quality of life analysis

A baseline tool for predicting response to peginterferon alfa‐2a in HBeAg‐positive patients with chronic hepatitis B

Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case‐control study in US male veterans

A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B

Index serum hyaluronic acid independently and accurately predicts mortality in patients with liver disease

Randomised clinical trial: 2% taurolidine versus 0.9% saline locking in patients on home parenteral nutrition

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN

Impact of patatin‐like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension

Systematic review and network meta‐analysis: first‐ and second‐line biologic therapies for moderate‐severe Crohn's disease

Systematic review with meta‐analysis: anxiety and depression in children and adolescents with inflammatory bowel disease

Systematic review with meta‐analysis: the prevalence of coeliac disease in patients with osteoporosis

Incidence of psoriasiform diseases secondary to tumour necrosis factor antagonists in patients with inflammatory bowel disease: a nationwide population‐based cohort study

Effects of vedolizumab, adalimumab and infliximab on biliary inflammation in individuals with primary sclerosing cholangitis and inflammatory bowel disease

Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium‐competitive acid blocker, in healthy male subjects

Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis

RNA sequencing confirms similarities between PPI‐responsive oesophageal eosinophilia and eosinophilic oesophagitis

Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti‐inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors

Intensity of surveillance for hepatocellular carcinoma determines survival in patients at risk in a hepatitis B‐endemic area

Stabilisation of acute‐on‐chronic liver failure patients before liver transplantation predicts post‐transplant survival

High body mass index is associated with increased risk of treatment failure and surgery in biologic‐treated patients with ulcerative colitis

Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial

Fibrosis‐4 index predicts cirrhosis risk and liver‐related mortality in 2075 patients with chronic HBV infection

Real‐world use of elbasvir‐grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network